Celanese Corporation — 2020 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2020. The filing also reports unaudited quarterly results, including the quarter ended December 31, 2020. Amounts are in U.S. dollars unless stated otherwise.
Business context
Celanese is a global chemical and specialty materials company operating through Engineered Materials, Acetate Tow and the Acetyl Chain. Its products serve automotive, medical, consumer, construction, packaging, food and beverage, and industrial markets. The company reported 7,658 employees and operated 33 production facilities, in addition to six strategic affiliate facilities, at year-end.
Financial performance and liquidity
| Metric | 2020 | 2019 |
|---|---|---|
| Net sales | $5.655 billion | $6.297 billion |
| Gross profit / margin | $1.293 billion / 22.9% | $1.606 billion / 25.5% |
| Operating profit / margin | $664 million / 11.7% | $834 million / 13.2% |
| Net earnings attributable to Celanese | $1.985 billion | $852 million |
| Diluted EPS | $16.75 | $6.84 |
| Cash provided by operations | $1.343 billion | $1.454 billion |
| Capital expenditures (cash-flow statement) | $364 million | $370 million |
Reported earnings include a $1.408 billion gain on the sale of Polyplastics; therefore, the sharp increase in net income and EPS does not reflect a comparable increase in operating profit. The sale generated approximately $1.6 billion in cash proceeds. The effective tax rate was 11%, versus 13% in 2019.
Year-end cash and cash equivalents were $955 million, with a further $533 million in marketable securities. Total debt was $3.723 billion, down from $3.905 billion; $496 million was classified as short-term borrowings and current debt. The company reported $1.25 billion available under its revolving credit facility and compliance with its debt covenants. Operating cash flow declined year over year. Investing activities provided $592 million, largely reflecting the Polyplastics sale, while financing activities used $1.471 billion, including dividends and share repurchases.
Segment results reflected pandemic-related demand and pricing pressure. Engineered Materials sales were $2.081 billion, down 12.8%, and operating profit was $235 million, down 47.3%. Acetate Tow sales fell 18.4% to $519 million, while operating profit rose to $118 million, mainly because the prior-year period included an $83 million impairment. Acetyl Chain sales declined 7.2% to $3.147 billion and operating profit fell 17.0% to $563 million.
For fourth-quarter 2020, sales were $1.591 billion, compared with $1.432 billion in fourth-quarter 2019. Operating profit was $203 million versus $68 million. Continuing-operations earnings attributable to Celanese were $1.453 billion versus $42 million, principally reflecting the Polyplastics gain recorded in the quarter.
Changes, outlook and notable items
- Full-year sales decreased 10%, with lower volume in Engineered Materials and Acetate Tow and lower pricing across all segments. COVID-19 reduced demand, particularly in the first half; demand improved in the second half, with automotive and consumer-goods demand in China and the U.S. described as having returned to pre-pandemic levels.
- Management said it expected demand and results to continue on a more normalized basis in 2021, assuming effective vaccine rollout and no resurgence of COVID-19. This is an expectation, not formal earnings guidance.
- 2021 capital expenditures were projected at $450–$500 million. Management expected $400–$500 million of additional share repurchases and stated it remained committed to the regular dividend. A quarterly dividend of $0.68 per share was declared in January 2021.
- The sale of Celanese’s 45% Polyplastics interest closed October 9, 2020 for approximately $1.6 billion; the company recorded a $1.408 billion gain and approximately $254 million of related income tax expense.
- The planned European Compounding Center of Excellence in Forli, Italy involves consolidating operations in Germany and Italy by 2022. The company recorded $34 million of related impairment, restructuring and accelerated depreciation costs in 2020 and expected approximately $44 million of additional exit and shutdown costs through 2022.
- The company reached a $92 million settlement with the European Commission concerning past ethylene purchases and paid it on January 12, 2021. Environmental remediation liabilities were $69 million; management said environmental costs were not expected to materially affect financial position, though they could materially affect results or cash flows in a given period.
Risks and contingencies
Key risks include the uncertain duration and economic effects of COVID-19; cyclical demand and competition; volatility or constrained availability of raw materials and energy; inability to pass cost increases through to customers; production disruptions, including weather and safety incidents; foreign-exchange exposure; regulatory, environmental and litigation matters; and debt, covenant and refinancing risks. Environmental, product-liability and other legal outcomes may exceed recorded estimates. The company also disclosed $3.355 billion of unconditional purchase obligations, primarily take-or-pay commitments, extending through 2042, and $447 million of expected pension and postretirement funding obligations in its contractual-obligations schedule.
Management reported effective disclosure controls and internal control over financial reporting as of December 31, 2020. KPMG issued unqualified opinions on the financial statements and internal control.
Important facts for investors to verify
- How much of 2020 earnings and EPS depended on the one-time Polyplastics gain, and what were underlying operating and cash-earnings trends?
- Whether demand recovery and pricing improvements continued in 2021, particularly in Engineered Materials and the Acetyl Chain.
- Debt maturities, refinancing plans and covenant headroom, including the $400 million notes due in 2021 and $500 million due in 2022.
- Actual costs and savings from the Forli consolidation, and whether the project meets the expected 2022 completion timeline.
- Developments in environmental and legal exposures, the European Commission settlement payment, and the company’s ability to meet its long-term purchase commitments.
- Cash returns to shareholders and planned capital spending relative to operating cash generation and liquidity needs.